What is the role of immune globulin in the management of measles?

Updated: Jun 06, 2019
  • Author: Selina SP Chen, MD, MPH; Chief Editor: Russell W Steele, MD  more...
  • Print

See the list below:

  • Clinicians can administer immune globulin either intramuscularly or intravenously within 6 days of exposure to prevent or modify measles response in people who lack evidence of measles immunity.

  • The recommended dose is 0.50 mL/kg administered intramuscularly, with a maximum volume of 15 mL.

  • Groups who are at higher risk for complications from severe measles should receive intravenous application at a dose of 400 mg/kg.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!